Jun 15 2020 |
Unpacking Differences in Public and Private Hospital M&A |
McDermott Will & Emery |
Jun 12 2020 |
A Virtual Discussion Series | Part I: Labor, Employment and OSHA Developments and Strategies for Companies and PE Investors Navigating COVID-19 Hurdles |
Wiggin and Dana LLP |
Jun 11 2020 |
Structuring Acquisitive Transactions in Difficult Times |
Katten |
Jun 10 2020 |
Energy & Sustainability M&A Activity — June 2020 |
Mintz |
Jun 9 2020 |
COVID-19: Distressed M&A in the UK and W&I Insurance Solutions to Warranty Coverage Issues |
K&L Gates |
Jun 5 2020 |
Proposed California Legislation Would Require State Approval for Health Care M&A and Prohibit Use of Health Care Market Power to Raise Price |
Polsinelli PC |
Jun 5 2020 |
NOL Carryback Rule Changes Bring Benefits For M&A Parties |
Polsinelli PC |
Jun 5 2020 |
Polish Government to Adopt Stricter Control over Private Investments |
Squire Patton Boggs (US) LLP |
Jun 4 2020 |
CA SB 977 Would Expand AG Review Of Healthcare Transactions |
McDermott Will & Emery |
Jun 4 2020 |
Dutch Court Decisions on Contractual Obligations During the COVID-19 Pandemic in an M&A Context |
Greenberg Traurig, LLP |
Jun 4 2020 |
Pre-merger Control Filing in China Concerning Variable Interest Entity Structures |
K&L Gates |
Jun 2 2020 |
Merger Transactions Reported to FTC, DOJ Reach 10-Year High |
Cornerstone Research |
Jun 2 2020 |
CFIUS Clearance: Huatai Securities, AssetMark Financial Holdings and WBI OBS Financial |
Squire Patton Boggs (US) LLP |
Jun 2 2020 |
A Comparison of the US Draft Vertical Merger Guidelines with the EU Non-Horizontal and the UK Merger Assessment Guidelines |
Cornerstone Research |
May 28 2020 |
Dining Delivery Disruptors Disrupted: DOJ, FTC Should Examine Uber’s Planned Purchase of Grubhub, Senators Say |
MoginRubin |
May 22 2020 |
Top Takeaways: Critical Business Considerations for Life Sciences and Medical Device Companies During COVID-19 |
McDermott Will & Emery |
May 22 2020 |
Top Takeaways: Permissible Provider Collaborations During COVID-19 and Beyond |
McDermott Will & Emery |
May 20 2020 |
And Now for Something Completely Different – EU Abuse Principles Sink Self-Serving Contract Variation |
Squire Patton Boggs (US) LLP |
May 19 2020 |
End of an Era: The U.S. is No Longer the Authority Figure for Multinational Mergers |
MoginRubin |
May 13 2020 |
COVID-19 and Material Adverse Effect in M&A Transactions |
Womble Bond Dickinson (US) LLP |
May 12 2020 |
CARES Act: Impact of revised net operating loss rules in M&A transactions |
Godfrey & Kahn S.C. |
May 8 2020 |
A Secret They Don’t Want to Keep: Buyer Sought to Terminate Deal for Victoria’s Secret |
Godfrey & Kahn S.C. |
May 7 2020 |
Does the Coronavirus Change the Material Adverse Event Clause for Mergers & Acquisitions? |
Mintz |
May 7 2020 |
COVID-19 Update: Antitrust Enforcement Remains Robust Despite COVID-19 |
Cadwalader, Wickersham & Taft LLP |
May 6 2020 |
Energy & Sustainability M&A Activity – May 2020 |
Mintz |
May 5 2020 |
COVID-19: Distressed M&A in the Era of a Pandemic |
K&L Gates |
May 4 2020 |
Recent Decision in Newmont Mining Reinforces the High Bar Buyers Face when Attempting to Establish a Material Adverse Event |
Mintz |
Apr 30 2020 |
COVID-19 and Poison Pills: The Right Prescription? |
Mintz |
Apr 30 2020 |
COVID-19: Proposed Legislation Would Prohibit Many Mergers and Acquisitions During Pandemic |
K&L Gates |
Apr 30 2020 |
Court of Chancery Applies Entire Fairness Standard to PennyMac’s Reorganization Transaction |
K&L Gates |
Apr 29 2020 |
How Antitrust Will Shape M&A During the Pandemic |
Foley & Lardner LLP |
Apr 29 2020 |
COVID-19 Impacts on the Copyright Office: What Does It Mean for Mergers and Acquisitions? |
Faegre Drinker |
Apr 27 2020 |
Is a Moratorium on Mergers During the Pandemic a Bridge Too Far? |
MoginRubin |
Apr 24 2020 |
M&A in the Investment Services Space – Help! My Deal Went Sideways… |
Norris McLaughlin P.A. |
Apr 22 2020 |
In Application of American Express to Horizontal Merger Challenge, District Court Allows Merger of Airline Ticket Platforms |
Mintz |
Apr 22 2020 |
United Technologies/Raytheon Highlights Key Issues in Aerospace and Defense Industry Merger Review |
McDermott Will & Emery |
Apr 21 2020 |
Poison Pills, NOL Poison Pills and the COVID-19 Pandemic |
Robinson & Cole LLP |
Apr 16 2020 |
Revisiting Guidance on MFN Terms |
Cornerstone Research |
Apr 16 2020 |
Force Majeure and Frustration in English Law M&A Agreements in the Context of COVID-19 |
Katten |
Apr 15 2020 |
How Will COVID-19 Impact M&A? |
Robinson & Cole LLP |
Apr 13 2020 |
Upcoming/New CFIUS Filing: ProSiebenSat.1 Media SE; General Atlantic Coöperatief U.A. and The Meet Group, Inc. |
Squire Patton Boggs (US) LLP |
Apr 13 2020 |
CFIUS Clearance: Capgemini and Leidos Cyber |
Squire Patton Boggs (US) LLP |
Apr 7 2020 |
Underestimated Risks: M&A and German Employee Inventions |
Squire Patton Boggs (US) LLP |
Apr 1 2020 |
Is a Pandemic a Material Adverse Event or Change in M&A? |
MoginRubin |
Apr 1 2020 |
Court Of Chancery Orders Specific Performance Of Merger Agreement, Finding That Fraud Contained In FDA Filings For Approval Of Target Product Did Not Rise To A “Material Adverse Effect” |
K&L Gates |
Apr 1 2020 |
In A Section 262 Appraisal Rights Proceeding, Chancery Court Accepts A Modified Version Of Petitioners’ Valuation Of A Merging Company’s Stock |
K&L Gates |
Mar 31 2020 |
Quarantining Deal Risk in the COVID-19 ERA: A Buyer's Checklist |
McDermott Will & Emery |
Mar 30 2020 |
Navigating the Pandemonium Raised by the Pandemic: Risk Mitigation in M&A |
Bracewell LLP |
Mar 28 2020 |
U.K. Begins Phase II Probe of Cengage/McGraw-Hill Merger |
MoginRubin |
Mar 26 2020 |
UPDATE - COVID-19: A Material Adverse Change in the UK? |
Greenberg Traurig, LLP |